Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 07, 2022 2:48pm
Another new low @48 cents
investors starting to figure out that they have been duped
(81)
•••
Stutters
X
View Profile
View Bullboard History
Comment by
Stutters
on Nov 06, 2022 12:33pm
RE: glass half full campfire stories by mr mugsy
I cant wait until this hits .30 cents. I wonder what MugsyGoof will say then.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 04, 2022 9:26am
RE:RE:There we are ...
Question is ... we hit a hard limit on the lowest possible dose for chronic and that limit complicated what was possible. Have we broken past that limit and can we go lower? I believe the answer
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 04, 2022 8:50am
RE:RE:RE:There we are ...
A couple details I can add there folks ... The key to the improved formulation is in the crystalline structure of 346 - OR shall I say - the processing that reduces the crystalline structure in the
...more
(174)
•••
Wriggles
X
View Profile
View Bullboard History
Comment by
Wriggles
on Nov 04, 2022 2:08am
RE:RE:There we are ...
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-non-opioid-analgesics-acute-pain-draft-guidance-industry Fully agree with that. I would add that
...more
(73)
•••
TriumphSpitSix
X
View Profile
View Bullboard History
Comment by
TriumphSpitSix
on Nov 04, 2022 12:30am
RE:There we are ...
"Just wish we really understood what "significant dose reduction" meant and how it affects Acute and Chronic drug development. Acute is easy to understand but how the dose
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 03, 2022 4:08pm
RE:RE:Mugsy is playing his game perfecy
Hahaha! You have no idea guilelesscat - the obsession from some of these guy extends way beyond the virtual walls of this ATE space. It's a little scary to see what some of them will do
...more
(43)
•••
guilelesscat
X
View Profile
View Bullboard History
Comment by
guilelesscat
on Nov 03, 2022 2:53pm
RE:Mugsy is playing his game perfecy
Bro obsession with mugsy is really creepy at this point. Chill out, both of you clearly have no life. I recommend going outside and touching some grass. Cheers.
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 03, 2022 12:32am
Mugsy is playing his game perfecy
posting tons today so everyone complains. That waY he doesnt do the dirty work while at the same time shorting the stock
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Nov 02, 2022 7:37pm
RE:starring mugs as the sheppard boy pez as the sheep wolf is
Pez is a lamb or baby sheep. And a dumb one for braging he bought shares at 0.60 lmao
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 02, 2022 10:31am
ATE shareholders are like a frog in boiling water
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 02, 2022 10:17am
ATE @50 cents 52 week low
(29)
•••
nobeard
X
View Profile
View Bullboard History
Comment by
nobeard
on Nov 02, 2022 9:26am
RE:ohhhhhh - scary !
Sale of Citigex ... There goes our safety blanket. Like a baby walking for the first time .. Come on you can do it!!
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Nov 02, 2022 9:25am
There we are ...
Finally - 6 months to the day ... roughly 180 days to close. The CITA back-up plan is no more. The final hurdle to co-listing is the price and don't look for anything short-term. Won't be
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 02, 2022 7:04am
New Press Release - Antibe Closes Previously Announced Strategic Sale of Citagenix Subsidiary
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, is pleased to announce the closing of the sale of its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”),...
read article.
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >